The optimal revascularization strategy for left main coronary artery disease (LMD) remains controversial, especially with two recent randomized controlled trials showing conflicting results. We sought to address this controversy with our analysis. 
Introduction
It is estimated that up to 6% of the patients undergoing coronary angiography may have significant left main coronary artery disease (LMD). 1 LMD patients are at a higher risk of cardiovascular events due to obstruction of blood flow to a large area of the left ventricle. 2 In addition, LMD coexists mostly with multi-vessel involvement and is frequently distal and calcific. 3 The optimal mode of revascularization [coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI)] of significant LMD has been debated for a long time due to the aforementioned characteristics of LMD. Current American College of Cardiology/American Heart Association guidelines 4 recommend CABG over PCI for all patients except for those in SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) score < _22, where PCI can be considered as a reasonable alternative. However, recently published, randomized controlled trials (RCTs) including NOBLE 5 and EXCEL 6 have added additional fuel to the ongoing controversy on the optimal strategy because of conflicting results. The NOBLE 5 trial found that CABG is superior to PCI for the treatment of patients with LMD. On the contrary, the EXCEL 6 trial concluded that PCI is non-inferior to CABG in such patients. There were differences in terms of primary endpoint (described below), visual vs. ultrasound determination of LMD severity by the heart team, and patient population enrolled across different SYNTAX score subcategories. NOBLE reported major adverse cardiac and cerebrovascular event [MACCE; composite of all-cause mortality, non-procedural myocardial infarction (MI), repeat revascularization, and stroke] as a primary outcome, whereas EXCEL reported composite rates of death, stroke, or MI as a primary outcome. 5, 6 Previously conducted meta-analyses comparing these two revascularization approaches are limited by non-inclusion of these two recent trials, lack of assessment of all important clinical outcomes, [7] [8] [9] limited assessment of effect of SYNTAX score (an index of LMD complexity), lack of assessment of outcomes at different times points, and the influence of patient characteristics on these outcomes. 10, 11 In light of the recent data and the aforementioned deficits in literature, we sought to conduct a meta-analysis comparing CABG and PCI to look at differences in clinical outcomes with LMD revascularization.
Material and methods
This systematic review was conducted and reported in accordance with Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA; see Supplementary material online, Table S1 ).
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We searched MEDLINE, PUBMED, and SCOPUS databases using the following keywords: left main disease, left main with PCI or CABG or drug eluting stent and randomized controlled trials from their inception to 1 December 2016 (specific keywords listed in Supplementary material online, Section S1). RCTs comparing the treatment effects of PCI vs. CABG on LMD revascularization in adult patients were identified and analysed using the following a priori defined inclusion criteria: (i) if the study was an RCT comparing PCI and CABG and (ii) the study reported data on the incidence of any of the desired post procedural clinical endpoints of death from any cause, MI, stroke, or ischaemia-driven target vessel revascularization. Case reports, editorials, comments, letters, review articles, guidelines, studies not including a control group, animal studies, imaging studies that solely reported non-clinical outcomes, and studies in non-English languages were excluded. When greater than one publication from the same patient population existed, then the study with the most complete data set was included for meta-analysis. All discrepancies in data extraction were resolved by consensus among senior author and authors collecting the data. After examining 1169 relevant studies, we included six RCTs 5, 6, 10, [13] [14] [15] that assessed and compared efficacy of the aforementioned revascularization approaches of LMD. Two authors (N.P. and A.B.) independently extracted data from each individual study. The Jadad Score 16 for RCTs was used to assess the data quality of the included studies by one author. The Jadad score 16 is calculated through examination of the methods of randomization, double blinding, and the number of dropouts. A higher score indicates a higher quality study. The primary outcome of interest was MACCE as reported in the trials. In addition, we also studied the effect of revascularization strategies on individual outcomes (e.g. death, stroke, and MI) that constituted our primary outcome. The relative risk ratio (RR) was chosen as the principal measure of effect. Furthermore, we conducted subgroup analyses comparing the effect of LMD revascularization treatment strategies on MACCE and individual outcomes by SYNTAX score categories and at various time points (30 days, 1 year, and end of follow-up (long-term)). Randomeffects modeling was used to estimate summary measures of association for all outcomes. Data were analysed for heterogeneity using the I 2 statistic proposed by Higgins and Thompson. 17 A two-sided P < 0.05 was considered statistically significant. All analyses were performed using STATA V14.1 (College Station, TX, USA) statistical software and Comprehensive Meta-Analysis version 2.2.046 (Biostat, Englewood, NJ, USA). Random-effects meta-regression using aggregate-level data to assess the effect of baseline patient characteristics of individual trials on the relative risk of MACCE was also performed. 18 One study removed sensitivity analysis and cumulative meta-analysis were also performed to assess the effect of individual studies on the primary outcome. [19] [20] [21] Egger's regression intercept 22 was used to determine the publication bias for RCTs comparing PCI vs. CABG for LMD revascularization. The trim-and-fill method was performed to correct the publication bias, as described by Duval and Tweedie. 23 
Results
We identified six RCTs 5,6,10,13-15 ( Figure 1 ) enrolling 4700 patients with LMD to study the role of PCI vs. CABG. All studies had at least 1 year of follow-up, with a range of 1 to 10 years. The individual study characteristics are shown in Table 1 . Definitions of MACCE as used in the individual RCTs is described in Table 2 . Of the 4700 patients, 2349 patients underwent PCI and 2351 underwent CABG. All included studies 5, 6, 10, 13, 14 were categorized as good quality, except LE MANS trial, 15 based on the Jadad quality score scale ( Table 3) . equipoise at 1 year between the two revascularization strategies ( Figure 5 ).
In addition, when we performed a separate analysis of three trials 5,10,13 which reported MACCE stratified by SYNTAX score, we observed a 37% higher risk of MACCE (RR 1.37, 95% CI 1.04-1.81) in patients undergoing PCI with SYNTAX score 33 and above when compared with those undergoing CABG ( Figure 4 , Panel B). However, the differences in MACCE risk were non-significant for those with SYNTAX score < _32 (RR 1.24, 95% CI 0.95-1.61) ( Figure 4 , Panel B).
Sensitivity and meta-regression analyses
We performed cumulative and one study removed analysis of the included trials, as the LEIPZIG 14 and NOBLE 5 trials had slightly different definitions of MACCE than other trials and the LE MANS trial 15 included a sizeable proportion of patients receiving bare metal stents. The RR for MACCE remained stable in both analysis indicating the robustness of our results ( Figure 6 , Panel A and B). Random-effects meta-regression to assess the effect of baseline patient characteristics in individual trials on the relative risk of MACCE showed that mean values of the patient-related characteristics did not have significant association with observed MACCE effects ( Table 4 ).
Publication bias assessment
The studies reporting MACCE in PCI vs. CABG groups are presented in the funnel plot ( Figure 7 ). Egger's weighted regression statistic (P = 0.42) indicated no significant publication bias. The Duval and Tweedie-corrected estimate for risk ratio did not differ significantly from the estimate derived by meta-analysis ( Figure 7 ).
Discussion
Recent large-scale RCTs 5, 6 have compared PCI vs. CABG with an endeavour to outline risks and benefits of revascularization strategies in patients with significant LMD. Traditional thinking has favoured CABG since it is postulated that surgical correction provides 'complete' revascularization and overall mortality benefit, given LMDs frequent association with calcification, distal vessel involvement, and coexistence with multi-vessel disease. 3 Our meta-analysis sought to clarify the disagreements in the data and deficits in the literature by including all the published RCTs to date. We demonstrate a noteworthy clinical benefit on long-term MACCE in favour of CABG for revascularization in patients with significant LMD, which was mainly driven by higher long-term repeat revascularization rates in the PCI arm when compared with CABG. On the contrary, rates of MACCE at 30 days were lower in the PCI when compared with CABG, which was mostly driven by lower rates of stroke in those undergoing PCI in comparison with CABG. At 1-year post procedure, MACCE rates were similar in two groups. This was due to higher stroke rates in the CABG arm which was balanced by higher revascularization rates in the PCI arm creating a clinical equipoise between the two revascularization strategies. However, at long-term follow-up, this trajectory of events eventually tilts the balance of the pendulum, i.e. lower overall MACCE risk in the CABG arm as depicted in our schematic figure. 24 This has been believed to be due to debris arising from the ascending aorta due to surgical manipulation (during cannulation), hypoperfusion during surgery, post-operative atrial fibrillation, and concomitant carotid artery disease prevalence. [25] [26] [27] [28] [29] This occurrence likely drives the MACCE rates in favour of PCI at 30 days.
On the other hand, PCI had inferior long-term rates of MACCE, which is likely explained by the fact that endothelial cells and medial wall are injured during PCI to varying degrees secondary to stretching by ballooning and stent placement. This leads to platelet activation, thrombus formation, and inflammation. 30 This possibly increases the restenosis rates requiring repeated interventions in the stented artery in comparison with CABG. Another explanation may be that arterial grafts have higher basal release of nitric oxide and endothelium-derived hyperpolarizing factor that may promote the vasodilatation of distal coronary arterial beds and, in turn, maintain myocardial perfusion and prevent recurrence of symptoms and repeat interventions. [31] [32] [33] [34] [35] To the best of our knowledge, ours is the largest meta-analysis of RCTs addressing the key question of an optimal revascularization Two points are awarded for randomization if the article described the method of randomization and it was appropriate. Two points are awarded for double blinding if it was both described and appropriate. If withdrawals/dropouts are described in the study then the study is awarded a single point. If either randomization or double blinding was not described or it was not appropriate, the study loses one point in each category. JADAD Score: 0 -2: poor quality, 3 -4: good quality, 5: excellent quality. grafting. Data are presented with risk ratios and 95% confidence intervals. Risk ratio at 30 days: MAACE was derived from EXCEL, PRECOMBAT, and LE MANS trials; all revascularization and myocardial infarction were derived from NOBLE, EXCEL, LEIPZIG, and LE MANS trials; stroke and allcause mortality were derived from NOBLE, EXCEL, and LE MANS trials. Risk ratio for 1 year outcomes were derived from SYNTAX, NOBLE, PRECOMBAT, LEIPZIG, and LE MANS trials. Risk ratio for at long-term outcomes were derived from SYNTAX, NOBLE, EXCEL, PRECOMBAT, LEIPZIG, and LE MANS trials. Panel B: Forest plot comparing outcomes stratified by SYNTAX score categories between percutaneous coronary intervention and coronary artery bypass grafting. Data are presented with risk ratios and 95% confidence intervals. Risk ratio for major adverse cardiac and cerebrovascular event was derived from SYNTAX, NOBLE, and PRECOMBAT trials and risk ratio for other outcomes was derived from SYNTAX and PRECOMBAT trials. CABG, Coronary artery bypass grafting; CI, Confidence intervals; MACCE, Major adverse cardiac and cerebrovascular events; PCI, Percutaneous coronary intervention; RR, Risk ratio. strategy (PCI vs. CABG) in patients with significant LMD. We did not observe any differences between PCI and CABG in terms of all-cause mortality and MI in our primary and subgroup analysis. Of note, this finding is different from the meta-analysis of the studies that have compared CABG and PCI for treatment of multi-vessel disease, 36 where CABG has been shown superior in reducing all-cause mortality and MI. Additionally, our finding that those with higher LMD complexity (SYNTAX score 33 and above) have better long-term MACCE rates with CABG is consistent with 5-year results of the SYNTAX trial. 10 Furthermore, our findings are concordant with only one other meta-analysis 11 that has compared PCI vs. CABG in patients with significant LMD after including EXCEL 6 and NOBLE 5 trials.
However, their investigation is limited by the lack of inclusion of the LE MANS trial, 15 lack of events being stratified by SYNTAX score, and lack of categorizing the change in risk in clinical outcomes over time with PCI vs. CABG. Limitations of meta-analyses, in general, are well recognized. 37 Definition of MACCE and its components differed slightly among studies. A patient-level meta-analysis of the data from the RCTs included in our analysis would be ideal to address some of the heterogeneity in the definition of MACCE. Nonetheless, our cumulative and one study removed sensitivity analyses did not change the observed results. Furthermore, the follow-up period of the RCTs included in our analysis ranged from 1 to 10 years. Since only LE 15 was with a follow-up of 10 years, it would be prudent to say that results of our analyses comparing PCI and CABG for LMD are applicable to the first 5 years after left main revascularization. Longer follow-up data from these RCTs 5, 6 would shed more light on this ongoing debate. In addition, our findings are not generalizable to the entire population, especially patients presenting with ST-segment elevation MI, those with contraindication to antiplatelet drugs, and concomitant valvular pathologies. Finally, due to the absence of patient-level data, we were not able to evaluate and compare for heterogeneity in patient-level covariates. Although we performed metaregression using aggregate-level data, these have limited validity beyond the range of dispersion of baseline characteristics of included RCTs (which were quite narrow). Several subgroups of patients, i.e. those with chronic kidney disease, severe left ventricular dysfunction, and older patients were not well represented in these RCTs. This highlights important areas of future research in specific populations with significant LMD. Until then, we suggest individualized decision making for each patient with significant LMD utilizing the heart-team approach.
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Conclusions
We have established that the intricate relationship between the complexity of LMD and clinical outcomes varies over time. Furthermore, there is lack of RCT data to assess the effect of extremes of patient characteristics on outcomes. Therefore, a careful discussion between the patient and a multidisciplinary heart team consisting of cardiovascular surgeons and interventionalists is warranted prior to decision making. Efforts should be made to further personalize the risk based on patient characteristics not captured in the traditional SYNTAX score. These approaches can aid in the determination of an 'individualized' strategy for revascularization in all patients with significant LMD.
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Egger's Regression Intercept 1-sided, P =0.42 Figure 7 Depiction of publication bias for major adverse cardiac and cerebrovascular events (MACCE) between percutaneous coronary intervention versus coronary artery bypass grafting. Hollow blue circles represent available studies. Hollow red circles represent imputed studies. The solid blue diamond is the log risk ratio for MACCE prior to publication bias adjustment. The solid red diamond is the log risk ratio for MACCE after publication bias adjustment.
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